Chemotherapy and programmed cell death protein 1/programmed death-ligand 1 inhibitor combinations for tyrosine kinase inhibitor-resistant, epidermal growth factor receptor-mutated non-small-cell lung cancer: a meta-analysis

Autor: Piotrowska, Z., Yeap, B.Y., Gainor, J.F.
Zdroj: In ESMO Open September 2024 9(9)
Databáze: ScienceDirect